Adverse Drug Reaction Classification System
Adverse Drug Reaction Classification System
| Drug ID |
Drug Name
|
CAS RN
|
Molecular Formula
|
Structure
|
| BADD_D00301 | Bromfenac sodium | 91714-93-1 | C15H11BrNNaO3 |  |
| BADD_D00302 | Bromhexine | 3572-43-8 | C14H20Br2N2 |  |
| BADD_D00303 | Bromocresol green | 76-60-8 | C21H14Br4O5S |  |
| BADD_D00304 | Bromocriptine | 25614-03-3 | C32H40BrN5O5 |  |
| BADD_D00305 | Bromocriptine mesylate | 22260-51-1 | C33H44BrN5O8S |  |
| BADD_D00306 | Budesonide | 51333-22-3 | C25H34O6 |  |
| BADD_D00307 | Bumetanide | 28395-03-1 | C17H20N2O5S |  |
| BADD_D00308 | Bupivacaine | 38396-39-3 | C18H28N2O |  |
| BADD_D00309 | Bupivacaine hydrochloride | 18010-40-7 | C18H29ClN2O |  |
| BADD_D00310 | Buprenorphine | 52485-79-7 | C29H41NO4 |  |
| BADD_D00311 | Buprenorphine hydrochloride | 53152-21-9 | C29H42ClNO4 |  |
| BADD_D00312 | Bupropion | 34911-55-2 | C13H18ClNO |  |
| BADD_D00313 | Bupropion hydrobromide | 905818-69-1 | C13H19BrClNO |  |
| BADD_D00314 | Bupropion hydrochloride | 31677-93-7 | C13H19Cl2NO |  |
| BADD_D00315 | Buserelin acetate | 68630-75-1 | C62H90N16O15 |  |
| BADD_D00316 | Buspirone | 36505-84-7 | C21H31N5O2 |  |
| BADD_D00317 | Buspirone hydrochloride | 33386-08-2 | C21H32ClN5O2 |  |
| BADD_D00318 | Busulfan | 55-98-1 | C6H14O6S2 |  |
| BADD_D00319 | Butabarbital | 125-40-6 | C10H16N2O3 |  |
| BADD_D00320 | Butabarbital sodium | 143-81-7 | C10H15N2NaO3 |  |
| BADD_D00321 | Butenafine | 101828-21-1 | C23H27N |  |
| BADD_D00322 | Butenafine hydrochloride | 101827-46-7 | C23H28ClN |  |
| BADD_D00323 | Butoconazole nitrate | 64872-77-1 | C19H18Cl3N3O3S |  |
| BADD_D00324 | Butorphanol | 42408-82-2 | C21H29NO2 |  |
| BADD_D00325 | Butorphanol tartrate | 58786-99-5 | C25H35NO8 |  |
| BADD_D00326 | Butylscopolamine bromide | 149-64-4 | C21H30BrNO4 |  |
| BADD_D00327 | C1 esterase inhibitor (recombinant) | 80295-38-1 | Not Available |  |
| BADD_D00328 | Cabazitaxel | 183133-96-2 | C45H57NO14 |  |
| BADD_D00329 | Cabergoline | 81409-90-7 | C26H37N5O2 |  |
| BADD_D00330 | Cabozantinib | 849217-68-1 | C28H24FN3O5 |  |